Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion description "[Here we report that BCL-2 protein expression of human glial tumors in vivo correlates with malignant transformation in that BCL-2 immunoreactive glioma cells were more abundant in WHO grade III/IV gliomas than in grade I/II gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion evidence source_evidence_literature NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion SIO_000772 7539458 NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion wasDerivedFrom befree-20140225 NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion wasGeneratedBy ECO_0000203 NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.